New Key Statistics Module, Z-Score and F-Score
XSAT:CSMED Key Ratios
| Market Cap kr M | 73.17 |
| Enterprise Value kr M | 85.42 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 35.80 |
| Price/Sales | 13.97 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) kr M | 4.00 |
| EPS (TTM) kr | -1.00 |
| Beneish M-Score | -4.5 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -5.79 |
| EV-to-EBITDA | -6.73 |
| PEG | -- |
| Shares Outstanding M | 13.81 |
| Net Margin (%) | -263.77 |
| Operating Margin % | -306.06 |
| Pre-tax Margin (%) | -344.12 |
| Quick Ratio | 0.19 |
| Current Ratio | 0.27 |
| ROA % (ttm) | -41.20 |
| ROE % (ttm) | -162.07 |
| ROIC % (ttm) | -40.93 |
| Dividend Yield % | -- |
| Altman Z-Score | -1.10 |
XSAT:CSMED Number of Guru Trades
XSAT:CSMED Volume of Guru Trades
Gurus Latest Trades with XSAT:CSMED
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
XSAT:CSMED is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers